Journals / Turkish Journal of Gastroenterology / 2022 / Cilt: 33 - Sayı: 4

A New Risk-Scoring System for Colorectal Cancer and Polyp Screening by Turkish Colorectal Cancer and Polyp Study Group

Pages
286–293
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Individuals with a score ≥ 4 must be included in the screening tests for colorectal cancer

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Colorectal cancer is one of the most commonly diagnosed types of cancer worldwide.
📊
Key Findings & Data:Methods: We enrolled 6508 subjects over the age of 18 from 16 centers, with colonoscopy screening.
💡
Conclusion & Impact:Individuals with a score ≥ 4 must be included in the screening tests for colorectal cancer
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background: Colorectal cancer is one of the most commonly diagnosed types of cancer worldwide. An early diagnosis and detection of colon cancer and polyp can reduce mortality and morbidity from colorectal cancer. Even though there are a variety of options in screen- ing tests, the question remains on which test is the most effective for the early detection of colorectal cancer. In this prospective study, we aimed to develop a simple, useful, effective, and reliable scoring system to detect colon polyp and colorectal cancer. Methods: We enrolled 6508 subjects over the age of 18 from 16 centers, with colonoscopy screening. The age, smoking status, alcohol consumption, body mass index, polyp incidence, polyp size, number and localization, and pathologic findings were recorded. Results: The age, male gender, obesity, smoking, and family history were found as independent risk factors for adenomatous polyp. We have developed a new scoring system which can be used for these factors. With a score of 4 or above, we found the following: sensitivity 81%, specificity 40%, positive predictive value 25.68%, and negative predictive value 89.84%, for adenomatous polyp detection; and sensitivity 96%, specificity 39%, positive predictive value 3.35%, negative predictive value 99.29%, for colorectal cancer detection. Conclusion: Even though the first colorectal cancer screening worldwide is generally performed for individuals over 50 years of age, we recommend that screening for colorectal cancer might begin for those under 50 years of age as well. Individuals with a score ≥ 4 must be included in the screening tests for colorectal cancer

🔖

Cite This Article

ERDEM, L., AKBAL, E., KOÇAK, E., TUCER, D., ÜÇBİLEK, E., UYANIKOĞLU, A., DOLAPÇIOĞLU, C., ERİM, E. A., ŞİRİN, G., ALKIM, H., SOYLU, A., DOĞANAY, L., KÜRBÜZ, A. K., ÖZDİL, K., ALAGÖZLÜ, H., ÖZTÜRK, T. E., SEZİKLİ, M., ADALI, G., ÇOBAN, M., HÜLAGÜ, S., DEĞE, H. (2022). A New Risk-Scoring System for Colorectal Cancer and Polyp Screening by Turkish Colorectal Cancer and Polyp Study Group. Turkish Journal of Gastroenterology, Cilt: 33 - Sayı: 4, 286–293. https://ajindex.com/articles/408399

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Epidemiology of colorectal cancer: incidence, mortality, sur- vival, and risk factors. Gut. 2017
  2. 66(4):683-691. [CrossRef] 2. Loomans-Kropp HA, Umar A. Increasing incidence of colorectal cancer in young adults. J Cancer Epidemiol. 2019
  3. 9841295. [CrossRef] 3. Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017
  4. 67(3):177-193. [CrossRef] 4. Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age- related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 2015
  5. 150(1):17-22. [CrossRef]. 5. Ahnen DJ, Wade SW, Jones WF, et al. The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin Proc. 2014
  6. 89(2):216-224. [CrossRef] 6. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal can- cer. Lancet. 1996
  7. 348(9040):1472-1477. [CrossRef] 7. Allison JE, Fraser CG, Halloran SP, Young GP. Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut Liver. 2014
  8. 8(2):117-130. [CrossRef] 8.Kim DH, Pickhardt PJ, Taylor AJ, et al. CT colonography versus colo- noscopy for the detection of advanced neoplasia. N Engl J Med. 2007
  9. 357(14):1403-1412. [CrossRef] 9. Ahlquist DA. Multi-target stool DNA test: a new high bar for non- invasive screening. Dig Dis Sci. 2015
  10. 60(3):623-633. [CrossRef] 10. Kirkegaard H, Johnsen NF, Christensen J, Frederiksen K, Over- vad K, Tjønneland A. Association of adherence to lifestyle recom- mendations and risk of colorectal cancer: a prospective Danish cohort study. BMJ. 2010
  11. c5504. [CrossRef] 11. Wei EK, Colditz GA, Giovannucci EL, Fuchs CS, Rosner BA. Cumu- lative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses’ Health Study. Am J Epidemiol. 2009
  12. 170(7):863-872. [CrossRef] 12. Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018
  13. 68(4):250-281. [CrossRef] 13. Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screen- ing: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2017
  14. 86(1):18-33. [CrossRef] 14. Slattery ML, Kerber RA